Maxalt and Malabsorption - a phase IV clinical study of FDA data

Summary:

Malabsorption is reported as a side effect among people who take Maxalt (rizatriptan benzoate), especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Malabsorption when taking Maxalt. It is created by eHealthMe based on reports of 11,566 people who have side effects when taking Maxalt from the FDA, and is updated regularly.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,753 Maxalt users. Check the latest studies of Maxalt.

What is Malabsorption?

Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract) is found to be associated with 652 drugs and 1,095 conditions by eHealthMe. Check the latest studies of Malabsorption.

On Apr, 25, 2026

11,566 people reported to have side effects when taking Maxalt.
Among them, 12 people (0.1%) have Malabsorption.

Among these 12 people:

How long have people been on Maxalt when they have Malabsorption? *

What is the gender of people who have Malabsorption when taking Maxalt? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Malabsorption when taking Maxalt? *

What are other drugs people take besides Maxalt? *

What are other side effects people have besides Malabsorption? *

Weight Decreased: 7 people, 58.33%
Diarrhea: 5 people, 41.67%
Dyspnea (difficult or laboured breathing): 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 4 people, 33.33%
Nausea And Vomiting: 4 people, 33.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 25.00%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 25.00%
Blood Glucose Fluctuation: 3 people, 25.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 25.00%
Depression: 3 people, 25.00%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 50.00%
Headache (pain in head): 3 people, 25.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Drowsiness: 3 people, 25.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 8.33%
Back Pain: 1 person, 8.33%
Constipation: 1 person, 8.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
Depression: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt and have Malabsorption?

- Check whether Malabsorption is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maxalt:

Maxalt (12,753 reports)

Malabsorption treatments and more:

Malabsorption (8,910 reports)

Browse all side effects of Maxalt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malabsorption:

Malabsorption (652 drugs)

Browse all the conditions that are associated with Malabsorption:

Malabsorption (1,095 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rizatriptan benzoate (the active ingredients of Maxalt) and Maxalt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.